[Specific treatments for chronic bacterial prostatitis and chronic pelvic pain syndrome].
OBJECTIVE
To review the treatment of chronic bacterial prostatitis and chronic pelvic pain syndrome (CPPS).


METHODS
A review of the literature was performed by searching the Medline database (National Library of Medicine). Search terms were either Medical subject heading (MeSH) keywords (antibacterial agents, pelvic pain, placebos, prostatitis, treatment) or terms derived from the title or abstract. Search terms were used alone or in combinations by using the "AND" operator. The literature search was conducted from 1990 to the present time.


RESULTS
The treatment of chronic bacterial prostatitis is based on the use of antibiotics, primarily fluoroquinolones, for 4 to 6 weeks, but no consensus has been reached concerning the standard treatment of CP/CPPS. A review of the literature failed to identify any recognized and validated treatments for CP/CPPS, but several conclusions can be drawn: placebo gives satisfactory results in a considerable number of patients; antibiotics are not recommended; alpha-blocking agents may be effective in recently diagnosed, previously untreated patients, provided they are prescribed for 12 weeks to 6 months; invasive surgery of the prostate and bladder neck is not recommended.


CONCLUSIONS
Progress in the treatment of CP/CPPS will require more extensive basic and clinical research. Only randomized, placebo-controlled clinical trials including a large number of patients, and using the NIH-Chronic Prostatitis Symptom Index questionnaire (NIH-CPSI) as evaluation tool will be able to provide reliable conclusions. The use of patient subgroups selected according to the predominant symptoms could be contributive.
Service d'urologie-andrologie, CHR La-Source, 14, avenue de l'Hôpital, 45067 Orléans cedex 2, France. delav.uro@orange.fr
D
D
Delavierre
J
J
Rigaud
L
L
Sibert
J-J
JJ
Labat
D001424:Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011472:Prostatitis / Q000188:drug therapy* / Q000382:microbiology*